79172291 - ACT IN

Information

  • Trademark
  • 79172291
  • Serial Number
    79172291
  • Registration Number
    5000641
  • Filing Date
    June 05, 2015
    8 years ago
  • Registration Date
    July 19, 2016
    7 years ago
  • Transaction Date
    October 31, 2023
    6 months ago
  • Status Date
    February 03, 2023
    a year ago
  • Published for Opposition Date
    May 03, 2016
    8 years ago
  • Location Date
    June 14, 2017
    6 years ago
  • Status Code
    709
  • Current Location
    TMO LAW OFFICE 120
    Employee Name
    FRIEDMAN, LESLEE ANN
  • Law Office Assigned Location Code
    N20
  • Owners
Mark Drawing Code
3000
Mark Identification
ACT IN
Case File Statements
  • DM0000: The mark consists of the literal element "act in" with both words stylized. The word "act" has a rounded triangle that is shaded at the tip of the curve of the lower case letter "t" which acts as the dot in the lower case letter "i" for the term "in".
  • B00001: In the statement, after health, line 8, " care " should be inserted. In the statement, after studies, line 19, " (scientific research for medical purposes ) " should be inserted.
  • GS0051: Products for medical use, namely, agents for the treatment of tumors in the field of radiation therapy; products for medical use, namely, agents for treatment of tumors using radiation therapy; radioactive products for medical use for treatment of tumors using radiation therapy; health * care * products, namely, pharmaceutical preparations for use in the treatment of tumors in the field of radiation therapy; radiological contrast substances for medical use in the treatment of tumors in the field of radiation therapy; chemical reagents for medical use in the treatment of tumors in the field of radiation therapy; chemical preparations for medical or pharmaceutical use in the treatment of tumors in the field of radiation therapy; drugs for medical use in the treatment of tumors in the field of radiation therapy; medicines for human medicine in the treatment of tumors in the field of radiation therapy; chemico-pharmaceutical products in the nature of chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of tumors in the field of radiation therapy; pharmaceutical products for the treatment of tumors in the field of radiation therapy; natural remedies in the realm of human medicine in the treatment of tumors in the field of radiation therapy; all these products for use in clinical studies * ( scientific research for medical purposes ) * concerning the treatment of tumors in the field of radiation therapy
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 10/31/2023 - 6 months ago
    40 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 10/7/2023 - 7 months ago
    39 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 10/7/2023 - 7 months ago
    38 - INVALIDATION PROCESSED Type: INPC
  • 10/3/2023 - 7 months ago
    37 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 2/3/2023 - a year ago
    36 - CANCELLED SECTION 71 Type: C71T
  • 2/22/2018 - 6 years ago
    35 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 2/14/2018 - 6 years ago
    34 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 6/14/2017 - 6 years ago
    33 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.
  • 6/14/2017 - 6 years ago
    32 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 4/12/2017 - 7 years ago
    31 - LIMITATION FROM THE IB EXAMINED AND ENTERED Type: LIME
  • 2/17/2017 - 7 years ago
    30 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 1/26/2017 - 7 years ago
    29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 11/22/2016 - 7 years ago
    28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/21/2016 - 7 years ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/21/2016 - 7 years ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 10/19/2016 - 7 years ago
    25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 7/19/2016 - 7 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/2/2016 - 7 years ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 5/3/2016 - 8 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/20/2016 - 8 years ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/20/2016 - 8 years ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 4/13/2016 - 8 years ago
    19 - NOTICE OF PUBLICATION Type: NPUB
  • 3/31/2016 - 8 years ago
    18 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN
  • 3/30/2016 - 8 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/29/2016 - 8 years ago
    16 - EXAMINERS AMENDMENT MAILED Type: CNEA
  • 3/29/2016 - 8 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/29/2016 - 8 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/25/2016 - 8 years ago
    13 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 3/17/2016 - 8 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/17/2016 - 8 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/17/2016 - 8 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/9/2015 - 8 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/22/2015 - 8 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/22/2015 - 8 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/19/2015 - 8 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/18/2015 - 8 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/18/2015 - 8 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/16/2015 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/14/2015 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/10/2015 - 8 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR